BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38046538)

  • 1. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats.
    Siregar S; Rulianov R; Ksatriapraja RA; Stefanus D
    F1000Res; 2022; 11():831. PubMed ID: 38046538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats.
    Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y
    J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan treatment significantly attenuates the fibrotic changes in the corpus cavernosum of castrated rats.
    Kucukdurmaz F; Efe E; Kurutas EB; Olmez C; Temizer M; Resim S
    Rev Int Androl; 2020; 18(1):14-20. PubMed ID: 30245178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intracorporeal Human Adipose-Derived Stem Cells (hADSCs) on Corpora Cavernosa Transforming Growth Factor β
    Siregar S; Adriansjah R; Sibarani J; Mustafa A
    Res Rep Urol; 2020; 12():21-27. PubMed ID: 32104667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
    Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
    Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway.
    Feng R; Wan J; He Y; Gong H; Xu Z; Feng J
    Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):19-27. PubMed ID: 36047789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats.
    Li WJ; Xu M; Gu M; Zheng DC; Guo J; Cai Z; Wang Z
    Cell Physiol Biochem; 2017; 42(1):333-345. PubMed ID: 28535536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
    Meng Y; Meng Y; Li X; Cai SX; Tong WC; Cheng YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):919-24. PubMed ID: 18583228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.
    Canguven O; Lagoda G; Sezen SF; Burnett AL
    J Urol; 2009 Jun; 181(6):2816-22. PubMed ID: 19375729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.
    Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G
    J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
    Zhao Y; Peng J; Zheng L; Yu W; Jin J
    Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria.
    Toblli JE; Ferder L; Stella I; De Cavanaugh EM; Angerosa M; Inserra F
    J Urol; 2002 Oct; 168(4 Pt 1):1550-5. PubMed ID: 12352456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.
    Wen J; Jiang X; Dai Y; Zhang Y; Tang Y; Sun H; Mi T; Phatarpekar PV; Kellems RE; Blackburn MR; Xia Y
    FASEB J; 2010 Mar; 24(3):740-9. PubMed ID: 19858092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
    Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
    Wei YH; Jun L; Qiang CJ
    Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two drugs with paradoxical effects on liver regeneration through antiangiogenesis and antifibrosis: Losartan and Spironolactone: a pharmacologic dilemma on hepatocyte proliferation.
    Parlakgumus A; Colakoglu T; Kayaselcuk F; Colakoglu S; Ezer A; Calıskan K; Karakaya J; Yildirim S
    J Surg Res; 2013 Jan; 179(1):60-5. PubMed ID: 22989552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the corpora cavernosa in patients with ischaemic priapism.
    Costa WS; Felix B; Cavalcanti AG; Medeiros J; Sampaio FJ
    BJU Int; 2010 Mar; 105(6):838-41; discussion 841. PubMed ID: 19751255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray micro-computed tomography in the assessment of penile cavernous fibrosis in a rabbit castration model.
    Kogan MI; Popov IV; Kirichenko EY; Mitrin BI; Sadyrin EV; Kulaeva ED; Popov IV; Kulba SN; Logvinov AK; Akimenko MA; Pasechnik DG; Tkachev SY; Karnaukhov NS; Lapteva TO; Sukhar IA; Maksimov AY; Ermakov AM
    Andrology; 2021 Sep; 9(5):1467-1480. PubMed ID: 34236146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart.
    Sun Y; Zhang JQ; Zhang J; Ramires FJ
    J Mol Cell Cardiol; 1998 Aug; 30(8):1559-69. PubMed ID: 9737942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.